Skip to content

Clinical trials

Terminated Myelodysplastic Syndromes trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Status: Terminated Country / region: Russia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20111
20141
20152
20171
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
St. Petersburg State Pavlov Medical University2
European Society for Blood and Marrow Transplantation1
Janssen Research & Development, LLC1
Kyntra Bio1
Traws Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes9
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Anemia1
Anemia, Refractory, with Excess of Blasts1
Hypereosinophilic Syndrome1
Immune System Diseases1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative1
Leukemia, Myelomonocytic, Chronic1
Lymphatic Diseases1
Myeloproliferative Disorders1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.